Germany's research-based pharmaceutical industry association, the VFA, has responded to a draft proposal by the Federal Department of Health to force drugmakers to supply pharmacies at least partly via wholesalers. The move is seen as an effort to prevent the recent trend towards direct-to-pharmacy distribution arrangements, which have especially been developed in the UK (Marketletters passim).
Cornelia Yzer, the VFA's chief executive, responded to the news, saying: "in principle, the pharmaceutical industry stands for a plurality of sales routes. Therefore the manufacturer must be able to make the decision whether he selects direct over wholesale." She criticized attempts to second-guess the most efficient distribution model by legislators, adding: "a competitive solution, which leaves it to the market, which delivery models succeed in the future, would be a better watchword."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze